Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Security class unavailable · CUSIP: 21077P108

Event date: 2021-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,000,000
Percent of class
6.2650%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000103
Form type
SC 13G
Filer
Context Therapeutics Inc.
CIK
CIK 1842952
Filed
Dec 06, 2021
Reporting period
Dec 02, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub